Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

  • March 4, 2026

Bayer has discontinued an early-stage clinical gene therapy for a rare genetic disorder in favor of a similar candidate.

Leave A Comment

Fields (*) Mark are Required